UV1 synthetic peptide vaccine and GM-CSF

BIOLOGICAL2 trials

Sponsors

Ultimovacs ASA

Conditions

Non-small Cell Lung CancerProstate Cancer

Phase 1

A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer

CompletedNCT01784913

Ultimovacs ASAProstate Cancer

Start: 2013-04-15End: 2020-10-23Updated: 2024-12-16

A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer.

CompletedNCT01789099

Ultimovacs ASANon-small Cell Lung Cancer

Start: 2013-04-08End: 2020-06-12Updated: 2024-12-16

Related Papers

Abstract 7441: Mapping immune clonotypes in prostate cancer using spatial V(D)J to resolve cancer vaccine response

Cancer Research2026-04-03

Predicting long-term results with circulating tumor cells in patients with de novo androgen sensitive prostate cancer treated with hTERT peptides vaccine.

Journal of Clinical Oncology2020-02-19